Last reviewed · How we verify
Vizol S DIGI EYE eye drops
Vizol S DIGI EYE eye drops are used to reduce intraocular pressure in patients with glaucoma.
Vizol S DIGI EYE eye drops are used to reduce intraocular pressure in patients with glaucoma. Used for Reduction of intraocular pressure in patients with glaucoma.
At a glance
| Generic name | Vizol S DIGI EYE eye drops |
|---|---|
| Also known as | Test, (T) |
| Sponsor | Jadran Galenski laboratorij d.d. |
| Drug class | prostaglandin analog |
| Target | PGF2α receptor |
| Modality | Small molecule |
| Therapeutic area | Ophthalmology |
| Phase | Phase 3 |
Mechanism of action
They work by reducing the amount of fluid produced in the eye, which helps to lower the pressure inside the eye. This can help to prevent damage to the optic nerve and preserve vision.
Approved indications
- Reduction of intraocular pressure in patients with glaucoma
Common side effects
- conjunctival hyperemia
- eye itching
- eye pain
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Vizol S DIGI EYE eye drops CI brief — competitive landscape report
- Vizol S DIGI EYE eye drops updates RSS · CI watch RSS
- Jadran Galenski laboratorij d.d. portfolio CI